2 min Read

Shilpa Medicare shares rise following CEP approval from EDQM for diabetes drug

Shilpa Medicare shares witnessed a notable gain on October 4, following an important regulatory milestone. The company's 100% subsidiary, Shilpa Pharma Lifesciences, received the Certificate...

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91